Bisphosphonate-incorporated coatings for orthopedic implants functionalization
Jiaxin Zhang,Haotian Bai,Miao Bai,Xiaonan Wang,ZuHao Li,Haowen Xue,Jincheng Wang,Yutao Cui,Hui Wang,Yanbing Wang,Rongqi Zhou,Xiujie Zhu,Mingwei Xu,Xin Zhao,He Liu
DOI: https://doi.org/10.1016/j.mtbio.2023.100737
IF: 8.2
2023-07-24
Materials Today Bio
Abstract:Bisphosphonates (BPs), the stable analogs of pyrophosphate, are well-known inhibitors of osteoclastogenesis to prevent osteoporotic bone loss and improve implant osseointegration in patients suffering from osteoporosis. Compared to systemic administration, BPs-incorporated coatings enable the direct delivery of BPs to the local area, which will precisely enhance osseointegration and bone repair without the systemic side effects. However, an elaborate and comprehensive review of BP coatings of implants is lacking. Herein, the cellular level (e.g., osteoclasts, osteocytes, osteoblasts, osteoclast precursors, and bone mesenchymal stem cells) and molecular biological regulatory mechanism of BPs in regulating bone homeostasis are overviewed systematically. Moreover, the currently available methods (e.g., chemical reaction, porous carriers, and organic material films) of BP coatings construction are outlined and summarized in detail. As one of the key directions, the latest advances of BP-coated implants to enhance bone repair and osseointegration in basic experiments and clinical trials are presented and critically evaluated. Finally, the challenges and prospects of BP coatings are also purposed, and it will open a new chapter in clinical translation for BP-coated implants.
engineering, biomedical,materials science, biomaterials